Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter declined from the prior quarter and also fell compared to the same period last year. The sequential and year-over-year decreases reflect a continued downward trend.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter declined from the prior quarter and also fell compared to the same period last year. The sequential and year-over-year decreases reflect a continued downward trend.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.2B
Revenue reported for this quarter.
Quarter-over-quarter
-1.0%
Change from the immediately preceding quarter.
Year-over-year
-5.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$45.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $11.2B | -3.5% |
| Dec 31, 2022 | $11.4B | -4.8% |
| Mar 31, 2023 | $11.3B | -2.7% |
| Jun 30, 2023 | $11.2B | -5.6% |
Revenue performance
The company's total revenue was lower than the preceding three-month period and the year-ago quarter. The quarterly performance extended the pattern of declining revenues seen in recent quarters.
Quarterly comparison
Compared to the immediately preceding quarter, revenue contracted. Versus the same quarter one year ago, the shortfall was more pronounced.
What to watch
The company's net debt decreased during the first half of the year, a development to monitor alongside revenue trends.